PT97164A - Processo para a estabilizacao de uma preparacao que contenham o composto 4-etil-2-hidroxi-imino-5-nitro-3-hexenamida e de composicoes farmaceuticas que o contenham - Google Patents

Processo para a estabilizacao de uma preparacao que contenham o composto 4-etil-2-hidroxi-imino-5-nitro-3-hexenamida e de composicoes farmaceuticas que o contenham

Info

Publication number
PT97164A
PT97164A PT97164A PT9716491A PT97164A PT 97164 A PT97164 A PT 97164A PT 97164 A PT97164 A PT 97164A PT 9716491 A PT9716491 A PT 9716491A PT 97164 A PT97164 A PT 97164A
Authority
PT
Portugal
Prior art keywords
hexenamide
nitro
ethyl
stabilizing
imino
Prior art date
Application number
PT97164A
Other languages
English (en)
Other versions
PT97164B (pt
Inventor
Yoshio Ueda Norio Onishi
Mitsuru Yasumura
Kazuto Okimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PT97164A publication Critical patent/PT97164A/pt
Publication of PT97164B publication Critical patent/PT97164B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT97164A 1990-03-28 1991-03-27 Processo para a estabilizacao de uma preparacao que contenham o composto 4-etil-2-hidroxi-imino-5-nitro-3-hexenamida e de composicoes farmaceuticas que o contenham PT97164B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8179090 1990-03-28
JP21305190 1990-08-10

Publications (2)

Publication Number Publication Date
PT97164A true PT97164A (pt) 1992-01-31
PT97164B PT97164B (pt) 1998-07-31

Family

ID=26422796

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97164A PT97164B (pt) 1990-03-28 1991-03-27 Processo para a estabilizacao de uma preparacao que contenham o composto 4-etil-2-hidroxi-imino-5-nitro-3-hexenamida e de composicoes farmaceuticas que o contenham

Country Status (15)

Country Link
EP (1) EP0452697B1 (pt)
JP (1) JPH0678227B2 (pt)
CN (1) CN1055355A (pt)
AT (1) ATE131044T1 (pt)
AU (1) AU642988B2 (pt)
CA (1) CA2038716A1 (pt)
DE (1) DE69115102T2 (pt)
DK (1) DK0452697T3 (pt)
ES (1) ES2080175T3 (pt)
GR (1) GR3018419T3 (pt)
HU (1) HU210641B (pt)
IE (1) IE71022B1 (pt)
IL (1) IL97648A (pt)
PT (1) PT97164B (pt)
RU (1) RU2023449C1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5270014A (en) * 1975-12-05 1977-06-10 Senju Pharma Co Stabilization of pyrido*3*22a*phenoxadine compounds
ZA838831B (en) * 1982-12-31 1984-07-25 Fujisawa Pharmaceutical Co New nitro aliphatic compounds,process for preparation thereof and use thereof

Also Published As

Publication number Publication date
IE910986A1 (en) 1991-10-09
IE71022B1 (en) 1997-01-15
ATE131044T1 (de) 1995-12-15
DE69115102T2 (de) 1996-05-15
HU210641B (en) 1995-06-28
ES2080175T3 (es) 1996-02-01
GR3018419T3 (en) 1996-03-31
HUT56488A (en) 1991-09-30
PT97164B (pt) 1998-07-31
AU642988B2 (en) 1993-11-04
EP0452697B1 (en) 1995-12-06
DK0452697T3 (da) 1996-01-02
EP0452697A1 (en) 1991-10-23
JPH0678227B2 (ja) 1994-10-05
DE69115102D1 (de) 1996-01-18
JPH04217915A (ja) 1992-08-07
CN1055355A (zh) 1991-10-16
IL97648A0 (en) 1992-06-21
RU2023449C1 (ru) 1994-11-30
CA2038716A1 (en) 1991-09-29
IL97648A (en) 1995-12-08
AU7381591A (en) 1991-10-03

Similar Documents

Publication Publication Date Title
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
DK0495982T3 (da) Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
DK551989D0 (da) 3-piperidinyl-1,2-benzisoxazoler, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DE68914438D1 (de) N-(3,4-dimethoxycinnamoyl)-Anthranilsäure enthaltende Arzneimittelzusammensetzungen.
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
DK0644199T3 (da) Cykliske antimikrobielle peptider og fremstilling deraf
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
CY1110261T1 (el) Παραγωγα της κουμαρινης που χρησιμοποιουνται σαν αντιπηκτικα
FI941723A (fi) Lipofiilisen oligosakkaridin antibiootin suolaa sisältävät seokset
SE9901573D0 (sv) New compounds
DK0583421T3 (da) Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
CY1107753T1 (el) 2,5-δισυποκατεστημενο 3-μερκαπτοπεντανοϊκο οξυ
PT97164A (pt) Processo para a estabilizacao de uma preparacao que contenham o composto 4-etil-2-hidroxi-imino-5-nitro-3-hexenamida e de composicoes farmaceuticas que o contenham
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
NO323556B1 (no) Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
ES2100768T3 (es) Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
DE69400283D1 (de) (Cyclohexyl)alkenderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
PE20030438A1 (es) Medicamento que comprende un derivado de eritromicina como agente antituberculoso
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910912

FG3A Patent granted, date of granting

Effective date: 19980420

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19991031